Ntshonga Pearl, Ntereke Tlhalefo Dudu, Zankere Tshiamo, Morse Daniel Paul, Koto Garesego, Gobe Irene, Paganotti Giacomo Maria
School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone Pvt Bag 0022, Botswana.
Botswana-University of Pennsylvania Partnership, Gaborone P.O. Box 45498, Botswana.
Antibiotics (Basel). 2025 Jun 30;14(7):662. doi: 10.3390/antibiotics14070662.
: The gene and its variant, , have been associated with resistance to antimicrobials and biocides. This poses a threat to infection prevention, control and treatment. Several studies investigated this relationship with conflicting results. The aim of this research was to determine the prevalence of and in clinical extended spectrum β-lactamase- (ESBL) and carbapenemase-producing spp. and spp. and elucidate the association of these genes with resistance to sodium hypochlorite. : This study included 216 isolates of ESBL- and carbapenemase-producing multidrug-resistant (MDR) spp. and spp. These isolates were identified by VITEK-2 analyser. The MIC and MBC of sodium hypochlorite were determined using the microbroth serial-dilution method. PCR was used to detect gene variants. A regression analysis investigated any association between genotypes, MIC and MBC, as well as antimicrobial drug resistance profiles. : Overall, there was a high prevalence of and variants (84.7%; 95% CI, 79.2-89.2). There was a high prevalence of (80.6%; 95% CI, 74.6-85.6) as compared to (15.3%, 95% CI, 10.8-20.8). The MIC and MIC of the isolates ranged between 7031 mg/L and 9375 mg/L and 14,060 mg/L and 18,750 mg/L, respectively, while the MBC ranged from 48,750 mg/L to 18,750 mg/L. There was no association between genotypes and high MIC and MBC as well as antimicrobial drug resistance. : The MIC and MBC of sodium hypochlorite are higher than what is currently used for disinfection in Botswana. There is a high prevalence of and ; however, these genes do not seem to be associated with resistance to sodium hypochlorite.
该基因及其变体与对抗菌药物和消毒剂的耐药性有关。这对感染的预防、控制和治疗构成了威胁。多项研究对这种关系进行了调查,但结果相互矛盾。本研究的目的是确定临床产超广谱β-内酰胺酶(ESBL)和碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌中该基因及其变体的流行情况,并阐明这些基因与对次氯酸钠耐药性的关联。:本研究纳入了216株产ESBL和碳青霉烯酶的多重耐药(MDR)肺炎克雷伯菌和大肠埃希菌。这些分离株通过VITEK-2分析仪进行鉴定。采用微量肉汤稀释法测定次氯酸钠的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。使用聚合酶链反应(PCR)检测基因变体。回归分析研究了该基因的基因型、MIC和MBC以及抗菌药物耐药谱之间的任何关联。:总体而言,该基因及其变体的流行率很高(84.7%;95%置信区间,79.2 - 89.2)。与变体(15.3%,95%置信区间,10.8 - 20.8)相比,该基因的流行率很高(80.6%;95%置信区间,74.6 - 85.6)。分离株的MIC和MBC分别在7031毫克/升和9375毫克/升以及14060毫克/升和18750毫克/升之间,而MBC范围为48750毫克/升至18750毫克/升。该基因的基因型与高MIC和MBC以及抗菌药物耐药性之间没有关联。:次氯酸钠的MIC和MBC高于博茨瓦纳目前用于消毒的浓度。该基因及其变体的流行率很高;然而,这些基因似乎与对次氯酸钠的耐药性无关。